Long-term prognostic value of positive peritoneal washing in colon cancer

被引:2
作者
Wind, P
Nordlinger, B
Roger, V
Kahlil, A
Guin, E
Parc, R
机构
[1] Univ Paris 06, Serv Chirurg Digest, Hop St Antoine, Dept Digest Surg, F-75571 Paris 12, France
[2] Hop Necker Enfants Malad, Dept Biostat, Paris, France
关键词
colon cancer; peritoneal cytology; peritoneal washing;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: We examined the potential prognostic value of free malignant cells in the peritoneal cavity of patients with colon adenocarcinoma. Methods: In 1991 and 1992, 88 patients underwent peritoneal washing with cytologic analysis immediately before elective colon resection for adenocarcinoma with no evidence of peritoneal metastases. Peritoneal washing fluid was collected before abdominal exploration, centrifuged immediately, and stained with the May-Grunwald-Giemsa and Harris Shorr methods. Malignancy was defined as recommended by Papanicolaou. Results: Free malignant cells in peritoneal fluid (positive peritoneal washing) were found in 25 of 88 (28%) patients (Dukes A, 0 of 11; Dukes B, 10 of 31; Dukes C, 11 of 37; Dukes D, 4 of 9). The positivity rate was 24 of 75 (32%) among patients with rumours involving the serous layer and 1 of 13 (8%) among the others (P = 0.0989). With a follow-up of 66.7 to 78.7 months the 5-year survival rates were 48% (95% confidence interval, 28.4-67.6) and 68% (95% CI, 56.2-79.8) among patients with positive and negative peritoneal washing, respectively (P = 0.09). Positive peritoneal washing was not significantly associated with survival in multivariate analysis. Conclusion: The presence of free malignant cells in the peritoneal cavity of patients with colon cancer provided no further prognostic information relative to the Dukes classification in this study. Nevertheless, further study is needed, particularly in a larger series of Dukes B patients, for whom a new prognostic factor would be useful for deciding adjuvant therapy.
引用
收藏
页码:606 / 610
页数:5
相关论文
共 27 条
[11]  
LEI SZ, 1994, ARCH SURG-CHICAGO, V129, P639
[12]   ABDOMINAL FLUID CYTOLOGY IN PATIENTS WITH GASTROINTESTINAL MALIGNANT LESIONS [J].
MARTIN, JK ;
GOELLNER, JR .
MAYO CLINIC PROCEEDINGS, 1986, 61 (06) :467-471
[13]   FREE MALIGNANT CELLS IN RELATION TO RECURRENCE OF CARCINOMA OF THE COLON [J].
MCGREW, EA ;
LAWS, JF ;
COLE, WH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1954, 154 (15) :1251-1254
[14]  
MICHELASSI F, 1990, SURGERY, V108, P787
[15]   LEVAMISOLE AND FLUOROURACIL FOR ADJUVANT THERAPY OF RESECTED COLON-CARCINOMA [J].
MOERTEL, CG ;
FLEMING, TR ;
MACDONALD, JS ;
HALLER, DG ;
LAURIE, JA ;
GOODMAN, PJ ;
UNGERLEIDER, JS ;
EMERSON, WA ;
TORMEY, DC ;
GLICK, JH ;
VEEDER, MH ;
MAILLIARD, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (06) :352-358
[16]  
MOORE G E, 1959, Dis Colon Rectum, V2, P92, DOI 10.1007/BF02616625
[17]  
NAKAJIMA T, 1978, ACTA CYTOL, V22, P221
[18]  
PAPANICOLAOU GN, 1954, ATLAS EXFIOLATIVE CY
[19]   POSTOPERATIVE RECURRENCE OF CANCER OF COLON DUE TO DESQUAMATED MALIGNANT CELLS [J].
POMERANZ, AA ;
GARLOCK, JH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1955, 158 (16) :1434-1436
[20]  
QUAN SHQ, 1959, SURGERY, V45, P258